Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer

Rohini Sharma, Hani Gabra, Ada E. Brooks et al.|British Journal of Cancer|2009

Cited by 65